Acute promyelocytic leukemia at time of relapse commonly demonstrates cytogenetic evidence of clonal evolution and variability in blast immunophenotypic features

American Journal of Clinical Pathology

Volumn 133, Issue 3, 2010, Pages 484-490

  Dimov, Nikolay D ^a   Medeiros, L Jeffrey ^a   Ravandi, Farhad ^a   Bueso Ramos, Carlos E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute promyelocytic leukemia; APL; Cytogenetics; Immunophenotype; PML RAR ; Relapse; t(15; 17)

Indexed keywords

ANTINEOPLASTIC AGENT; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; RETINOIC ACID; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLAST CELL; CANCER RELAPSE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPHENOTYPING; MALE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; ADOLESCENT; CHILD; CYTOGENETICS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFANT; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77949349104     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPJ7K0AWMBHMAI     Document Type: Article

References (27)

1. Tallman MS, Altman JK. Curative strategies in acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program. 2008:391-399.
2. Cantu-Rajnoldi A, Biondi A, Jankovic M, et al. Diagnosis and incidence of acute promyelocytic leukemia (FAB M3 and M3 variant) in childhood. Blood. 1993;81:2209-2210. (Pubitemid 23106740)
3. Avvisati G, Lo Coco F, Mandelli F. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Semin Hematol. 2001;38:4-12. (Pubitemid 32107698)
4. Stone RM, Mayer RJ. The unique aspects of acute promyelocytic leukemia. J Clin Oncol. 1990;8:1913-1921.
5. Nagendra S, Meyerson H, Skallerud G, et al. Leukemias resembling acute promyelocytic leukemia, microgranular variant. Am J Clin Pathol. 2002;117:651-657. (Pubitemid 34823697)
6. Lin P, Hao S, Medeiros LJ, et al. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004;121:402-407. (Pubitemid 38298174)
7. Tallman MS, Nabhan C. Management of acute promyelocytic leukemia. Curr Oncol Rep. 2002;4:381-389.
8. Ferrara F, Palmieri S, Mele G. Prognostic factors and therapeutic options for relapsed or refractory acute myeloid leukemia. Haematologica. 2004;89:998-1008. (Pubitemid 39049910)
9. Chow J, Feusner J. Isolated central nervous system recurrence of acute promyelocytic leukemia in children. Pediatr Blood Cancer. 2009;52:11-13.
10. Specchia G, Lo Coco F, Vignetti M, et al. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol. 2001;19:4023-4028. (Pubitemid 32976688)
11. Reiter A, Lengfelder E, Grimwade D. Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia. Acta Haematol. 2004;112:55-67. (Pubitemid 38716250)
12. Kohno A, Morishita Y, Iida H, et al. Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group. Int J Hematol. 2008;87:210-216.
13. Lengfelder E, Gnad U, Buchner T, et al. Treatment of relapsed acute promyelocytic leukemia. Onkologie. 2003;26:373-379. (Pubitemid 37140395)
14. Yin CC, Glassman AB, Lin P, et al. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol. 2005;123:840-848. (Pubitemid 40740681)
15. Khoury JD, Sen F, Abruzzo LV, et al. Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol. 2003;34:1022-1029. (Pubitemid 37315254)
16. Schreck RR, Distèche CM, Adler D. ISCN standard idiograms. Curr Protoc Hum Genet. 2001;Appendix 4:Appendix 4B.
17. De Botton S, Chevret S, Sanz M, et al. Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 Trial. Br J Haematol. 2000;111:801-806. (Pubitemid 32098918)
18. Gallagher RE, Schachter-Tokarz EL, Zhou DC, et al. Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure. Leukemia. 2006;20:556-562.
19. Callens C, Chevret S, Cayuela JM, et al. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group. Leukemia. 2005;19:1153-1160. (Pubitemid 40945998)
20. Grimwade D, Lo Coco F. Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia. Leukemia. 2002;16:1959-1973. (Pubitemid 35203438)
21. Cassinat B, de Botton S, Kelaidi C, et al. When can real-time quantitative RT-PCR effectively define molecular relapse in acute promyelocytic leukemia patients (results of the French Belgian Swiss APL Group)? Leuk Res. 2009;33:1178-1182.
22. Goemans BF, Tamminga RY, Corbijn CM, et al. Outcome for children with relapsed acute myeloid leukemia in the Netherlands following initial treatment between 1980 and 1998: survival after chemotherapy only? Haematologica. 2008;93:1418-1420.
23. Liso V, Specchia G, Pogliani EM, et al. Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. Cancer. 1998;83:1522-1528. (Pubitemid 28465469)
24. Evans GD, Grimwade DJ. Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma. 1999;33:219-229. (Pubitemid 29196859)
25. Kai T, Kimura H, Shiga Y, et al. Recurrent extramedullary relapse of acute promyelocytic leukemia after allogeneic stem cell transplantation: successful treatment by arsenic trioxide in combination with local radiotherapy. Int J Hematol. 2006;83:337-340. (Pubitemid 43807579)
26. Lee KW, Yi J, Yun T, et al. Extramedullary relapse confirmed by fluorescence in situ hybridization study of an ear mass in acute promyelocytic leukemia. Int J Hematol. 2004;79:462-464. (Pubitemid 38808362)
27. Tobita T, Shinjyo K, Yanagi M, et al. Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid. Intern Med. 1997;36:484-486. (Pubitemid 27349310)